iPreg Inc. (好孕行生醫) is a biomedical device manufacturer focused on reproductive medicine. The company, established in 2018, has developed the innovative "iPreg sperm sorting chip" designed to address the discernible difference in swimming ability between healthy and abnormal sperm. This technology caters to the global population of infertility, which stands at around 15%. The chip has shown the potential to increase the healthy sperm ratio to 90% within 30 minutes, significantly improving safety, recovery, and efficiency in key processes such as IVF and sperm screening. The company's headquarters is located in Taiwan. This innovative solution has the potential to make a significant impact on the field of reproductive medicine. With infertility being a widespread issue, iPreg's technology presents a promising opportunity to improve the success rates of assisted reproduction. As the company continues to develop and commercialize its product, it may attract interest from venture capital firms looking to invest in groundbreaking biomedical technologies.
There is no investment information
No recent news or press coverage available for iPreg Inc. / 好孕行生醫.